Quantinuum has unveiled a third-generation quantum computer that could be easier to scale up than rival approaches. The US- and UK-based company Quantinuum today unveiled Helios, its third-generation ...

SOUTH SAN FRANCISCO, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway ...

Two former Plymouth County prosecutors have their careers on the line after a Board of Bar Overseers hearing panel found “unacceptable” misconduct on their part in a case that put a Brockton High ...

NFL teams trimmed their respective rosters from 90 players down to the 53-man active limit on Tuesday. In the wake of those moves, several players involved in those roster cuts will return or sign ...

Mutations in the gene encoding PI3Kα are associated with several types of cancer, but selectively targeting oncogenic signalling while leaving physiological PI3Kα activity intact has proved ...

A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating side effect. The compound was developed by Lawrence Livermore National ...

Boron is an essential micronutrient required for plant cell wall integrity, as it is necessary for crosslinking the pectic polysaccharide rhamnogalacturonan II. Reproductive organs require a greater ...

BridgeBio Oncology Therapeutics, a company working to advance the field of therapies addressing a validated but elusive group of cancer targets, has reached a deal to go public in a SPAC merger that ...

For a while, special purpose acquisition companies were biotech’s hot ticket to the public markets. While interest in this path has died down in recent years, BridgeBio’s former cancer unit thinks it ...

SOUTH SAN FRANCISCO & BOSTON--(BUSINESS WIRE)--TheRas, Inc. d/b/a BridgeBio Oncology Therapeutics (“BBOT”), a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel ...